Completed

No Applicants // Limit: 1 // Tickets Available: 1

The purpose of this NOFO is to solicit proposals from highly qualified clinical sites in the US to join the Network through an X01 Resource Access Program award. Accepted sites will be designated as a “Diagnostic Center of Excellence (DCoE)” and will be responsible for generating participant clinical, phenotypic and sequencing data to be submitted to the DMCC through a Data Use Agreement with the Center.  X01 recipients will have access to DMCC resources and infrastructure including access to high-quality phenotypic and genotypic data and collaboration with highly skilled physicians, researchers, and bioinformaticians. Using team science, DCoEs will be able to collaborate with Network members to implement strategies that will expand equity and accessto health disparity populations and increase the discovery of new disease-associated genes and genomic variants, immunologic and metabolic abnormalities, as well as environmental insults that are causative in previously undiagnosed patients. DCoEs will be invited to submit their most challenging, unsolved cases for acceptance into the Network, and partner in their evaluation with the Network’s virtual case review committee(s), which will be coordinated by the DMCC.

Successful applicants will demonstrate that they have the appropriate expertise and a track record of diagnosing rare and difficult-to-diagnose disorders, along with the infrastructure and resources needed to conduct the clinical evaluation and DNA sequencing of participants enrolled at their sites. Specifically, applicants will be expected to demonstrate the expertise, independent resources (e.g., institutional support, plans for billing insurance, obtaining support from outside partnerships, etc.), and capacity to:

• Enroll a minimum of 5 participants per year who are accepted into the Network, although some sites may have the capacity to enroll more participants. Typically, only the most difficult, unsolved cases will be accepted into the Network (e.g., those cases requiring specialized, non-routine diagnostic testing procedures or collaboration among a team of clinicians and researchers).
• Perform comprehensive clinical evaluations of undiagnosed participants enrolled at their site including medical record review, routine and specialized diagnostic testing procedures, consultations, and referral to other sites with necessary expertise if appropriate.
• Have the resources (in-house or outsourced) to perform DNA and/or RNA sequencing and re-analysis of existing genome-sequencing data.
• Capability to work with Network data stored in a cloud architecture, such as AnVIL.
• Have the genomics capability including medical genetics and associated informatics expertise needed to identify pathogenic variants from human genomics sequence data. This includes the infrastructure to return genetic results to study participants and provide post-test genetic counseling.
• Demonstrate sufficient clinical metabolomics and other omics expertise to interpret or re-interpret lab and research-grade findings.
• Have sufficient clinical staff to review medical records from applicants (so as to enroll a minimum of five cases per year into the Network) and to rigorously discuss the results to arrive at a diagnosis or to interrogate candidate genes.
• Collect and store DNA, fibroblasts from skin biopsies, and other biological specimens produced by clinical evaluations as needed for the diagnosis.
• Organize incoming records and return results to participants, family members, and referring physicians.
• Support a site coordinator or equivalent position to serve as the DCoE’s point of contact for data sharing, case coordination, collaboration, data retrieval for research projects and patient follow-up.

No applicants // Limit: 1 // Tickets Available: 1 

Only one application can be submitted per institution. Each application submitted under this announcement must address one, and only one, of the Project Areas.

Through this grant program, EPA is soliciting applications to assist in the development and utilization of innovative activities relating to workforce development and career opportunities in the water utility sector, which may include:
(A) expanding the use and availability of activities and resources that relate to the recruitment, including the promotion of diversity within that recruitment, of individuals to careers in the drinking water and wastewater utility sector, including stormwater;
(B) expanding the availability of training opportunities for (i) individuals entering the water and wastewater utility sector; and (ii) individuals seeking to advance careers within the water and wastewater utility sector;
(C) expanding the use and availability of activities and strategies, including the development of innovative activities and strategies, that relate to the maintenance and retention of a sustainable workforce in the water and wastewater utility sector; and
(D) expanding the availability of workforce development and training that enables drinking water and wastewater utility workers to reduce greenhouse gas (GHG) emissions and other air pollutants to benefit disadvantaged communities. 

Project areas:

• Project Area 1: Targeted internship, apprenticeship, pre-apprenticeship, and post-secondary bridge programs for skilled water utility trades.
• Project Area 2: Education programs designed for elementary, secondary, and higher education students.
• Project Area 3: Regional industry and workforce development collaborations to address water utility employment needs and coordinate candidate development, particularly in areas of high unemployment or for water utilities with a high proportion of retirement eligible employees.
• Project Area 4: Leadership development, occupational training, mentoring, or cross-training programs that ensure incumbent drinking water and wastewater utility workers are prepared for higher level supervisory or management-level positions.
• Project Area 5: Education and training programs, including internship or apprenticeship programs, designed for decentralized water workers (i.e., private well and/or septic system service professionals) to support public health outcomes for communities that rely on private wells for drinking water or decentralized systems for adequate treatment and disposal of wastewater.

Institutionally Coordinated // Limit: 1 // PI: R. Sorensen (Community Engagement, Family and Community Medicine)

Only one proposal per organization will be accepted in this grants cycle.

Delta Dental of Arizona Foundation is now accepting applications for the 2024 competitive grant cycle. Programs must benefit underserved, uninsured populations (all ages) and applicants must be an Arizona-based 501(c)3 non-profit, government agency, school or charitable program with a fiscal agent. 

Grants ranging $5,000 to $30,000 are available to support the following areas:

• Dental disease prevention
• Oral health education
• Dental treatment
• Medical-dental integration
• Food insecurity and access programs, nutritional programs

Institutionally Coordinated // PIs: 
R. Goyal (Obstetrics and Gynecology)
A. Gallitano (Research Series - Basic Medical Sciences)
M. Cai (Chemistry and Biochemistry)
I.Gladysheva (Research Series - Internal Medicine)
G.Gurtner (Surgery)
S.Goldman (Cardiology)
Z.Li (Orthopaedic Research)
P. Govindappa (Orthopaedic Surgery)
M. Ahmed (Neonatology)
A. Avellino (Pediatric Neurosurgery)
C. Curiel-Lewandrowski (Dermatology)
E. Erickson (Nursing)/ S. Aras (Sensor Analysis & Smart Platforms)
H.Li (Pharmacology and Toxicology)
M. Johnson (Immunobiology)
J. Lacombe (Research Series - Basic Medical Sciences)
R. Liang (Optical Sciences)
E. Enikov (Aerospace and Mechanical Engineering)
C.Hulme (Chemistry and Biochemistry)

Submissions will require an institutional letter of support. Because of this support requirement, this is an Institutionally Coordinated Submission. 

The Flinn Foundation’s 2023 Seed Grants to Promote Translational Research Program will fund up to 10 research teams focused on advancing new products or services to improve patient care. The teams must be affiliated with Arizona’s academic research institutions and/or health-care systems.

The awardees will each receive a $100,000 grant over 18 months. At the end of the grant period, up to two of the most successful projects may receive up to an additional $100,000 over the following year.

The proposed projects must address compelling clinical needs in the areas of precision medicine, diagnostics, devices, therapeutics, or health-care-delivery processes and have significant potential to turn bench results into viable products or systems impacting patients in Arizona and beyond.

Limit: 1  // PI: V. Kamath (Basic Medical Sciences)

The objective of the BRF Seed Grant Program is to support new and innovative projects, especially those of junior faculty, who are working in new research directions.To be eligible, PI must be a full-time Assistant or Associate Professor working in the area of studies of brain function. This includes molecular and clinical neuroscience as well as studies of neural, sensory, motor, cognitive, behavioral and emotional functioning in health and disease. Each total grant is limited to $80,000 (direct costs) for a two year grant period. Funding is to be directed at pilot research projects that are both innovative and will likely lead to successful grant applications to NIH and other public and private funding entities.

Eligibility
To be eligible, PI must be a full-time Assistant or Associate Professor at an invited US academic institution, working in the area of studies of brain function. This includes molecular and clinical neuroscience as well as studies of neural, sensory, motor, cognitive, behavioral and emotional functioning in health and disease. The grant proposal must detail a new research project that is not funded by other sources. This grant is not to be used as bridge funding.

Investigators at institutions that are affiliated with a medical school or university are eligible to apply only through the institution where they hold a full-time faculty position.

Scientists that have previously received a BRF Seed Grant may not receive the award for a second time unless all grant requirements from all previous awards are met. Only one PI may apply per application.

Institutionally Coordinated // Limit: 3* // PI:  E-J. Lee (Electrical and Computer Engineering)

*UArizona is invited to submit up to three nominations, one for each of the three disciplinary categories: Life Sciences; Physical Sciences & Engineering; and Chemistry.

The Blavatnik National Awards for Young Scientists recognize the United States' most promising faculty-rank researchers in Life Sciences, Physical Sciences & Engineering, and Chemistry. One Blavatnik National Awards Laureate in each disciplinary category will receive $250,000 in unrestricted funds, and additional nominees will be recognized as Finalists.

Interested applicants or nominators should contact Marie Teemant, Associate, Research Development Services.

Limit: 2  // PIs: 
Kenry (Pharmaceutics & Pharmacokinetics)
S. Song (Biomedical Engineering)

Only two nominations are allowed per institution.

These competitive research awards provide seed money for junior faculty members that often result in additional funding from other sources. The award amount provided by ORAU is $5,000. The applicant’s institution is required to match the award with at least an additional $5,000. This is a one-year grant (June 1 to May 31).

Eligibility for the Powe Awards is open to full-time assistant professors at ORAU member institutions within two years of their tenure track appointment at the time of application. If there is a question about eligibility, your ORAU Councilor makes the final determination. Only two nominations are allowed per institution.

Research projects must fall within one of these five disciplines:

• Engineering and Applied Science
• Life Sciences
• Mathematics/Computer Sciences
• Physical Sciences
• Policy, Management, or Education

Junior faculty members interested in applying should consult their ORAU Councilor, and visit the frequently asked questions.

 The University of Arizona Cancer Center (UACC) coordinates the selection process for this limited submission opportunity. For more information, please contact: UACC-PreAward@arizona.edu 

UACC Limited Submission Information:

The University of Arizona Cancer Center (UACC) can nominate one application for the NCI Predoctoral to Postdoctoral Fellow Transition Award (F99/K00) for FY2024.

Purpose of Award:

The UACC is seeking nominations for an NCI Predoctoral to Postdoctoral Fellow Transition Award (F99/K00) which is to encourage and retain outstanding graduate students recognized by their institutions for their high potential and strong interest in pursuing careers as independent cancer researchers. The award will facilitate the transition of talented graduate students into successful cancer research postdoctoral appointments and provide opportunities for career development activities relevant to their long-term career goals of becoming independent cancer researchers.

This Notice of Funding Opportunity (NOFO) does not allow applicants to propose to lead an independent clinical trial, but does allow applicants to propose research experience in a clinical trial led by a sponsor or co-sponsor.

Applicant Eligibility:

• Any individual(s) with the skills, knowledge, and resources necessary to carry out the proposed research as the Program Director(s)/Principal Investigator(s) (PD(s)/PI(s)) is invited to work with their organization to develop an application for support. Individuals from diverse backgrounds, including underrepresented racial and ethnic groups, individuals with disabilities, and women are always encouraged to apply for NIH support.
• An applicant must be a citizen or a noncitizen national of the United States, or has been lawfully admitted for permanent residence (i.e., possess a currently valid Permanent Resident Card USCIS Form I-551, or other legal verification of such status), or be a non-U.S. citizen with a valid U.S. visa. For applications submitted on behalf of non-U.S. citizens with valid U.S. visas, the visa status during each phase of the F99/K00 award must allow the PD/PI to conduct the proposed research at the applicant institution. For the F99 phase of the award, the applicant F99 institution is responsible for determining and documenting, in the nomination letter, that the applicant's visa will allow the applicant to remain in the U.S. to complete the F99 phase of the award, and that there are no known obstacles that would prevent the applicant from obtaining a visa for the K00 phase. For the K00 phase of the award, the U.S institution at which the K00 phase of the award will be conducted is responsible for determining and documenting, in the transition application, that the PD/PI’s visa will allow the PD/PI to remain in the U.S. for the duration of the K00 award. NCI may request verifying information as part of the pre-award process.
• The applicant must have a baccalaureate degree and be currently enrolled as a graduate student in the third or fourth year of a mentored PhD or equivalent research degree program (e.g., DrPH, ScD) in the biomedical, behavioral, or clinical sciences at a domestic institution. F99 eligibility is determined from the date of enrollment as a graduate student at the PhD institution and includes the time spent to earn a MS degree unless there was a major change in research area and a change in research mentor. The applicant must be at the dissertation research stage of training at the time of award, and must show evidence of high academic performance in the sciences and commitment to a career as an independent cancer research scientist.
• This program is expected to enhance the research career trajectories of cancer researchers and foster progression to research independence. K00 awardees remain eligible to apply to subsequent mentored Career Development (K) and Pathway to Independence (K99/R00) award programs.
• The F99/K00 award may not be used to support studies leading to the MD, DDS, or other clinical, health-professional degree (e.g., DC, DMD, DNP, DO, DPM, DVM, ND, OD, AuD). Students matriculated in a dual-degree program (e.g. MD/PhD, DO/PhD, DDS/PhD, or DVM/PhD) are not eligible for the F99/K00 program.

Institutionally Coordinated // Limit: 1 // PI: R. Deil-Amen ( College of Education)
 

UArizona may submit one proposal.

Through this solicitation, NSF seeks to foster a network of S-STEM stakeholders and further develop the infrastructure needed to generate and disseminate new knowledge, successful practices and effective design principles arising from NSF S-STEM projects nationwide. The ultimate vision of the legislation governing the S-STEM parent program[1] (and of the current S-STEM-Net solicitation) is that all Americans, regardless of economic status, should be able to contribute to the American innovation economy if they so desire.

To support collaboration within the S-STEM network, NSF will fund several S-STEM Research Hubs (S-STEM-Hub). The S-STEM Network (S-STEM-Net) will collaborate to create synergies and sustain a robust national ecosystem consisting of multi-sector partners supporting domestic low-income STEM students in achieving their career goals, while also ensuring access, inclusion, and adaptability to changing learning needs. The Hubs will investigate evolving barriers to the success of this student population. It will also disseminate the context and circumstances by which interventions and practices that support graduation of domestic low-income students (both undergraduate and graduate) pursuing careers in STEM are successful.

The target audience for this dissemination effort is the community of higher education institutions, faculty, scholars, researchers and evaluators, local and regional organizations, industry, and other nonprofit, federal, state, and local agencies concerned with the success of domestic low-income STEM students in the United States.

Limit: 1  // PI:  M. Romero-Ortega (Bioengineering)

One application per institution (normally identified by having a unique DUNS number or NIH IPF number) is allowed. This FOA seeks to support programs that include innovative approaches to enhance biomedical engineering (BME) designeducation to ensure a future workforce that can meet the nation’s needs in biomedical research and healthcare technologies.

Applications are encouraged from institutions that propose to establish new or to enhance existing team-based design courses orprograms in undergraduate biomedical engineering departments or other degree-granting programs with biomedical engineeringtracks/minors. This FOA targets the education of undergraduate biomedical engineering/bioengineering students in a team-basedenvironment. Health equity and universal design topics must be integrated throughout the educational activities. While current bestpractices such as multidisciplinary/interdisciplinary education, introduction to the regulatory pathway and other issues related tothe commercialization of medical devices, and clinical immersion remain encouraged components of a strong BME program, thisFOA also challenges institutions to propose other novel, innovative and/or ground-breaking activities that can form the basis of thenext generation of biomedical engineering design education.